# OnCo record philippe-moreau (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/philippe-moreau/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "philippe-moreau" ;
  schema:name "Philippe Moreau"@en ;
  schema:description "Led MajesTEC-1 and CASSIOPEIA, bringing the first bispecific antibody and daratumumab quadruplets to myeloma."@en ;
  schema:url <https://onco.cc/people/philippe-moreau/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Moreau%20P%5BAuthor%5D%20myeloma%20teclistamab%20OR%20daratumumab> ;
  onco:tag "myeloma", "bispecific", "trialist" ;
  schema:jobTitle "Head of the Hematology Department, University Hospital Hôtel-Dieu, Nantes" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:technologies <https://onco.cc/technologies/bispecific-antibody/>, <https://onco.cc/technologies/t-cell-engager/> ;
  onco:targets <https://onco.cc/targets/bcma/>, <https://onco.cc/targets/cd38/>, <https://onco.cc/targets/cd3/> ;
  onco:drugs <https://onco.cc/drugs/teclistamab/> ;
  onco:institutions <https://onco.cc/institutions/chu-nantes/> ;
  onco:trials <https://onco.cc/trials/majestec-1/>, <https://onco.cc/trials/majestec-3/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-majestec-1-teclistamab-nejm-2022/> ;
  schema:affiliation <https://onco.cc/institutions/chu-nantes/> .